Clinical Trial: Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07732075) titled 'Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis' on July 23.

Brief Summary: This study aims to evaluate the Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects with Healed Erosive Esophagitis

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Maintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD)

Intervention: DRUG: JP-1366 10 mg

Orally, once daily

DRUG: Lansoprazole 15mg

Orally, once daily

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Onconic Therapeutics Inc.

Published by HT Digital Content Services wit...